Article Details

Analysts take a look at Sarepta Therapeutics, Inc. (NASDAQ:SRPT) having this to say.

Retrieved on: 2018-02-17 20:22:30

Tags for this article:

Click the tags to see associated articles and topics

Analysts take a look at Sarepta Therapeutics, Inc. (NASDAQ:SRPT) having this to say.. View article details on hiswai:

Excerpt

<div>First Tru Advisors L P accumulated 57,668 shares. <b>Benchmark Capital</b> reported 0.72% stake. Artal Grp Sa invested 0.16% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). Putnam Llc reported 17,374 shares stake. Since October 3, 2017, it had 0 insider buys, and 1 sale for $575,000 activity.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo